Cigna Corp. (NYSE:CI) shares dropped 3.6% during mid-day trading on Monday . The company traded as low as $140.03 and last traded at $140.78, with a volume of 2,448,729 shares changing hands. The stock had previously closed at $146.00.

CI has been the subject of a number of analyst reports. Leerink Swann restated a “buy” rating and set a $175.00 price objective on shares of Cigna Corp. in a report on Thursday, March 31st. Zacks Investment Research lowered shares of Cigna Corp. from a “hold” rating to a “sell” rating in a research note on Monday, April 11th. Jefferies Group reaffirmed a “buy” rating and issued a $165.00 price target (down previously from $184.00) on shares of Cigna Corp. in a research note on Tuesday, May 10th. Royal Bank Of Canada lifted their price target on shares of Cigna Corp. from $169.00 to $174.00 and gave the company a “sector perform” rating in a research note on Wednesday, May 18th. Finally, Barclays PLC lifted their price target on shares of Cigna Corp. from $156.00 to $168.00 and gave the company an “equal weight” rating in a research note on Wednesday, June 1st. Six analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $165.19.

The company has a market cap of $35.97 billion and a PE ratio of 17.53. The company’s 50-day moving average is $129.80 and its 200-day moving average is $134.04.

Cigna Corp. (NYSE:CI) last posted its quarterly earnings data on Friday, May 6th. The company reported $2.32 EPS for the quarter, topping the consensus estimate of $2.16 by $0.16. During the same period last year, the business earned $1.96 EPS. The company earned $9.90 billion during the quarter, compared to the consensus estimate of $9.98 billion. The firm’s quarterly revenue was up 4.4% compared to the same quarter last year. Analysts predict that Cigna Corp. will post $9.29 EPS for the current year.

Other hedge funds have added to or reduced their stakes in the company. FineMark National Bank & Trust boosted its stake in Cigna Corp. by 12.1% in the fourth quarter. FineMark National Bank & Trust now owns 24,278 shares of the company’s stock valued at $3,553,000 after buying an additional 2,611 shares in the last quarter. Tredje AP fonden boosted its stake in Cigna Corp. by 0.9% in the fourth quarter. Tredje AP fonden now owns 17,555 shares of the company’s stock valued at $2,569,000 after buying an additional 163 shares in the last quarter. Twin Capital Management Inc. boosted its stake in Cigna Corp. by 14.7% in the fourth quarter. Twin Capital Management Inc. now owns 45,516 shares of the company’s stock valued at $6,660,000 after buying an additional 5,830 shares in the last quarter. Sawtooth Asset Management Inc. boosted its stake in Cigna Corp. by 3,602.8% in the fourth quarter. Sawtooth Asset Management Inc. now owns 10,738 shares of the company’s stock valued at $1,571,000 after buying an additional 10,448 shares in the last quarter. Finally, Morgan Stanley boosted its stake in Cigna Corp. by 22.5% in the fourth quarter. Morgan Stanley now owns 1,987,289 shares of the company’s stock valued at $290,798,000 after buying an additional 365,130 shares in the last quarter.

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, Other Operations and Corporate.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.